Masimo 'disappointed' in Q2 results, confirms slashed guidance
Masimo shares fell this morning after the company shared second-quarter results that included slashed 2023 guidance.
Source: massdevice.com
📰 Sam Eiber News
Page 4 - Sam Eiber News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sam Eiber. Real-time updates on events, politics, business and more.
Masimo loses board seats to activist investor Politan
Masimo shareholders voted to oust two members of the device developer's board after a heated battle by Politan Capital Management.
Source: massdevice.com
Analysts still high on Insulet despite Medtronic's EOFlow buy
Despite a negative reaction following a major buy in the insulin delivery space, analysts still back Insulet (Nasdaq:PODD) stock to perform.
Source: massdevice.com
Senseonics Holdings, Inc. (AMEX:SENS) Q1 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Senseonics First Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode.
Source: insidermonkey.com
iRhythm faces another subpoena from the DOJ
Wearable cardiac monitor developer iRhythm disclosed its third subpoena in more than two years from federal investigators.
Source: massdevice.com
Insulet Corporation (NASDAQ:PODD) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Insulet Corporation First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Source: insidermonkey.com
Masimo trade secret suit against Apple ends in mistrial
The ongoing patent spat between Masimo (Nasdaq:MASI) and Apple has another twist as a judge declared a mistrial yesterday.
United States Sam Eiber Marie Thibault Us International Trade Commission United States Trade Commission Apple Watch
Source: massdevice.com
Abbott completes $890M acquisition of Cardiovascular Systems
Abbott[WtwhTicker symbol='ABT'](NYSE:ABT)[/WtwhTicker] announced today that it completed its acquisition of Cardiovascular Systems.
Source: massdevice.com
Acutus Medical stock is down despite Street-beating Q4
Acutus Medical shares took a hit today despite fourth-quarter results that came in ahead of the consensus forecast.
Source: massdevice.com
Analysts receive update on Embecta insulin patch pump progress
BTIG analysts met with Embecta executives last week and received an update on the company's current position.
Source: massdevice.com